238 related articles for article (PubMed ID: 22739198)
21. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.
Ito M; Hiramatsu H; Kobayashi K; Suzue K; Kawahata M; Hioki K; Ueyama Y; Koyanagi Y; Sugamura K; Tsuji K; Heike T; Nakahata T
Blood; 2002 Nov; 100(9):3175-82. PubMed ID: 12384415
[TBL] [Abstract][Full Text] [Related]
22. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene.
King M; Pearson T; Shultz LD; Leif J; Bottino R; Trucco M; Atkinson MA; Wasserfall C; Herold KC; Woodland RT; Schmidt MR; Woda BA; Thompson MJ; Rossini AA; Greiner DL
Clin Immunol; 2008 Mar; 126(3):303-14. PubMed ID: 18096436
[TBL] [Abstract][Full Text] [Related]
23. Cell separation improves the sensitivity of detecting rare human normal and leukemic hematopoietic cells in vivo in NOD/SCID mice.
Holyoake TL; Horrocks C; Thomas T; Eaves CJ; Eaves AC
Cytotherapy; 2000; 2(6):411-21. PubMed ID: 12044221
[TBL] [Abstract][Full Text] [Related]
24. The induction of CD10 on a pre-B leukemia cell line occurs with progression of the disease in scid mice.
Ishii E; Greaves A; Grunberger T; Freedman MH; Letarte M
Leukemia; 1993 Oct; 7(10):1592-601. PubMed ID: 7692193
[TBL] [Abstract][Full Text] [Related]
25. In utero transplantation of human fetal haemopoietic cells in NOD/SCID mice.
Turner CW; Archer DR; Wong J; Yeager AM; Fleming WH
Br J Haematol; 1998 Nov; 103(2):326-34. PubMed ID: 9827901
[TBL] [Abstract][Full Text] [Related]
26. High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase.
Wang JC; Lapidot T; Cashman JD; Doedens M; Addy L; Sutherland DR; Nayar R; Laraya P; Minden M; Keating A; Eaves AC; Eaves CJ; Dick JE
Blood; 1998 Apr; 91(7):2406-14. PubMed ID: 9516140
[TBL] [Abstract][Full Text] [Related]
27. Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice.
Simpson-Abelson MR; Sonnenberg GF; Takita H; Yokota SJ; Conway TF; Kelleher RJ; Shultz LD; Barcos M; Bankert RB
J Immunol; 2008 May; 180(10):7009-18. PubMed ID: 18453623
[TBL] [Abstract][Full Text] [Related]
28. Establishment of a reproducible model of chronic-phase chronic myeloid leukemia in NOD/SCID mice using blood-derived mononuclear or CD34+ cells.
Lewis ID; McDiarmid LA; Samels LM; To LB; Hughes TP
Blood; 1998 Jan; 91(2):630-40. PubMed ID: 9427719
[TBL] [Abstract][Full Text] [Related]
29. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.
Bonnet D; Bhatia M; Wang JC; Kapp U; Dick JE
Bone Marrow Transplant; 1999 Feb; 23(3):203-9. PubMed ID: 10084250
[TBL] [Abstract][Full Text] [Related]
30. The effect of human fetal liver-derived mesenchymal stem cells on CD34+ hematopoietic stem cell repopulation in NOD/Shi-scid/IL-2Rã(null) mice.
Yang HM; Cho MR; Sung JH; Yang SJ; Nam MH; Roh CR; Kim JM; Shin M; Song SH; Kwon CH; Joh JW; Kim SJ
Transplant Proc; 2011 Jun; 43(5):2004-8. PubMed ID: 21693316
[TBL] [Abstract][Full Text] [Related]
31. Engraftment of low numbers of pediatric acute lymphoid and myeloid leukemias into NOD/SCID/IL2Rcγnull mice reflects individual leukemogenecity and highly correlates with clinical outcome.
Woiterski J; Ebinger M; Witte KE; Goecke B; Heininger V; Philippek M; Bonin M; Schrauder A; Röttgers S; Herr W; Lang P; Handgretinger R; Hartwig UF; André MC
Int J Cancer; 2013 Oct; 133(7):1547-56. PubMed ID: 23526331
[TBL] [Abstract][Full Text] [Related]
32. [Optimization of conditions for human erythropoiesis in human-mouse xenotransplant model].
Zheng WW; Xu FF; Yin RH; Zhan YQ; Yang XM; Li ZY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1606-11. PubMed ID: 24370057
[TBL] [Abstract][Full Text] [Related]
33. Cobblestone area-forming cells, long-term culture-initiating cells and NOD/SCID repopulating cells in human neonatal blood: a comparison with umbilical cord blood.
Zhang XB; Li K; Fok TF; Li CK; James AE; Lam AC; Lee SM; Yuen PM
Bone Marrow Transplant; 2002 Nov; 30(9):557-64. PubMed ID: 12407429
[TBL] [Abstract][Full Text] [Related]
34. Characterization of human B cells in umbilical cord blood-transplanted NOD/SCID mice.
Wang X; Qi Z; Wei H; Tian Z; Sun R
Transpl Immunol; 2012 Mar; 26(2-3):156-62. PubMed ID: 22198522
[TBL] [Abstract][Full Text] [Related]
35. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice.
Greiner DL; Shultz LD; Yates J; Appel MC; Perdrizet G; Hesselton RM; Schweitzer I; Beamer WG; Shultz KL; Pelsue SC
Am J Pathol; 1995 Apr; 146(4):888-902. PubMed ID: 7717456
[TBL] [Abstract][Full Text] [Related]
36. An assay for human hematopoietic stem cells based on transplantation into nonobese diabetic recombination activating gene-null perforin-null mice.
Minamiguchi H; Wingard JR; Laver JH; Mainali ES; Shultz LD; Ogawa M
Biol Blood Marrow Transplant; 2005 Jul; 11(7):487-94. PubMed ID: 15983548
[TBL] [Abstract][Full Text] [Related]
37. [Hematopoietic repopulating ability of human CD34+ cells and CD34- cells in NOD/SCID mice].
Jin H; Cai H; Yang S; Tan W
Sheng Wu Gong Cheng Xue Bao; 2008 Sep; 24(9):1588-94. PubMed ID: 19160842
[TBL] [Abstract][Full Text] [Related]
38. Intrathymic injection of hematopoietic progenitor cells establishes functional T cell development in a mouse model of severe combined immunodeficiency.
Tuckett AZ; Thornton RH; O'Reilly RJ; van den Brink MRM; Zakrzewski JL
J Hematol Oncol; 2017 May; 10(1):109. PubMed ID: 28511686
[TBL] [Abstract][Full Text] [Related]
39. Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment.
Pearson T; Shultz LD; Miller D; King M; Laning J; Fodor W; Cuthbert A; Burzenski L; Gott B; Lyons B; Foreman O; Rossini AA; Greiner DL
Clin Exp Immunol; 2008 Nov; 154(2):270-84. PubMed ID: 18785974
[TBL] [Abstract][Full Text] [Related]
40. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.
Feuring-Buske M; Gerhard B; Cashman J; Humphries RK; Eaves CJ; Hogge DE
Leukemia; 2003 Apr; 17(4):760-3. PubMed ID: 12682634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
